Strengths, Weaknesses, Opportunities, and Threat Analysis of LAFOV Total-Body PET/CT in Cardiovascular Imaging
| Parameter | Description |
|---|---|
| Strengths | Whole-body coverage |
| High spatial and temporal resolution | |
| Dynamic imaging | |
| Short imaging time | |
| Low radiation dose | |
| Opportunities | New development in medical imaging |
| Clinical cardiovascular trials | |
| Biodistribution of newly developed (radiolabeled) cardiovascular drugs | |
| Insights of cardiovascular and multiorgan interaction/cross-talk | |
| Artificial intelligence implementation | |
| Weaknesses | CT for attenuation correction, as significant limit to dose reduction (although ultra-low-dose CT, time-of-flight correction, or deep-learning approach will be implemented soon) |
| Requirement for accurate motion correction | |
| Data storage and networking infrastructure | |
| Lack of easy-to-use clinical kinetic software programs | |
| Number of patient preparation rooms | |
| Threats | Costs |
| Not widely available | |
| Computational times for reconstruction, data corrections, and kinetic modeling |